These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8400114)

  • 21. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
    Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
    Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
    Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
    Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
    Burgers JA; Bruynzeel PL; Mengelers HJ; Kreukniet J; Akkerman JW
    J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
    Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675.
    Handley DA; Van Valen RG; Winslow CM; Tomesch JC; Saunders RN
    Thromb Haemost; 1987 Apr; 57(2):187-90. PubMed ID: 3037718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of receptors for platelet-activating factor in guinea pig lung membranes.
    Gomez J; Bloom JW; Yamamura HI; Halonen M
    Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
    Hwang SB; Wang S
    Mol Pharmacol; 1991 Jun; 39(6):788-97. PubMed ID: 2051992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
    Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.